NEWS & VIEWS

Global private equity and venture capital news and research

Swift part-exit for Longitude as Esperion eyes IPO weeks after investmentp

12 Jun 2013

Venture investors in biopharmaceutical business Esperion Therapeutics are preparing to sell down their stakes through an IPO just weeks after the company completed a $33m preferred financing round.

Sorry, you have reached your quota of 1 free article a week or you are attempting to read a Premium story. To read more, simply sign-up to our daily newsletter.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014